SHANGHAI – Biotech acquisitions are increasingly becoming a part of the Chinese outbound investment story. This time around, up and comer Zhejiang Betta Pharmacuetical Co. has made a commitment to invest $20 million in equity in Xcovery Inc., of West Palm Beach, Fla.